Tender detail
Selective immunosuppressants – Eculizumab IV.
Summary
The tender concerns the supply of parenteral immunosuppressive medicines containing the active substance eculizumab (ATC L04AJ01) for treatment of patients in approved indications according to the SmPC. The planned contract duration is 48 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.